In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

NEED HELP?

Read the Frequently Asked Questions for a better use

READ MORE

 

Refine your search
Sponsor

ESC Congress 365

Your free access to ESC Congress content all year long 

The online library to view thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime & without subscription!

To make the most of it watch the tutorial video or check out the FAQ!

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by AstraZeneca.

AstraZeneca
Abstract Slides/e-posters Video Report Interview
 
Optimal initiation of dual anti-platelet therapy – Reviewing the evidence. Discussion.
Presenter: S James (Uppsala,SE)
2015
more
 
Summary and close - Targeting the high-risk patient: evolving concepts on optimally modifying risk by lipid-modulating therapies.
Presenter: C M Ballantyne (Houston,US)
2015
more
 
Introduction - Targeting the high-risk patient: evolving concepts on optimally modifying risk by lipid-modulating therapies.
Presenter: C M Ballantyne (Houston,US)
2015
more
 
Dual anti-platelet therapy after acute coronary syndromes – should we continue beyond 12 months? Pro.
Presenter: M Sabatine (Boston,US)
2015
more
 
Welcome and session objectives - Dual anti-platelet therapy in 2015 – Reviewing the evidence.
Presenter: P G Steg (Paris,FR)
2015
more
 
Dual anti-platelet therapy after acute coronary syndromes – should we continue beyond 12 months? Contra.
Presenter: N Danchin (Paris,FR)
2015
more
 
A new approach to statin treatment: lipid lowering therapy guidelines in the US.
Presenter: C M Ballantyne (Houston,US)
2014
more
 
PLATO: impact on the management of acute coronary syndromes and the future with PARTHENON.
Presenter: P G Steg (Paris,FR)
2014
more
 
Closing remarks - Back in Barcelona with PLATO: 5 years of practice, guidelines and controversies.
Presenter: L C Wallentin (Uppsala,SE)
2014
more
 
Discussion - Early initiation of antiplatelet therapy.
Presenter: P G Steg (Paris,FR)
2014
more

ESC Congress 365 only features resources for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

AstraZeneca AstraZeneca